Subtle Medical raises $33M to scale AI imaging across MRI, PET, and CT

Subtle Medical is a healthcare AI funding story that should have been included in a broader daily sweep. The company provides AI-powered medical imaging software and says the new $33 million growth-capital round was anchored by a Series C financing led by Morgan Stanley Expansion Capital. Shinhan Venture Investment and existing backers including Fusion Fund, EnvisionX, BRV, and Samsung Ventures also participated, bringing total capital raised to $86 million. Subtle Medical says it will use the money to accelerate product development, expand global adoption, and scale a vendor-neutral AI imaging platform across MRI, PET, and CT workflows. This is a company announcement, but the round is specific and relevant to real clinical AI deployment.

Key details: June 2, 2026, $33 million growth capital, Subtle Medical, Morgan Stanley Expansion Capital, Ohad Arazi CEO, $86 million total capital raised, MRI, PET.

Continue swiping for more AI Brief stories.